McAvoy David R.
Insider CIK 1758842 · ECYT General Counsel · TEVA EVP, Chief Legal Officer · BBI General Counsel and CCO
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| TEVA TEVA PHARMACEUTICAL INDUST | P Buy | 2025-09-05 | 2025-09-09 | 1,113 | $18.86 | $21.0K | 13,027 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | A Award deriv | 2025-03-05 | 2025-03-07 | 56,603 | — | $0 | 56,603 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | S Sale | 2025-03-05 | 2025-03-06 | 1,677 | $15.91 | $26.7K | 11,914 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise deriv | 2025-03-04 | 2025-03-06 | 16,741 | — | $0 | 50,223 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | S Sale | 2025-03-04 | 2025-03-06 | 3,150 | $15.73 | $49.5K | 13,591 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise | 2025-03-04 | 2025-03-06 | 16,741 | — | $0 | 16,741 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | A Award deriv | 2024-03-04 | 2024-03-05 | 66,964 | — | $0 | 66,964 | SEC↗ |
| FRTX Fresh Tracks Therapeutics, | M Exercise deriv | 2023-10-02 | 2023-10-04 | 20,000 | — | $0 | 0 | SEC↗ |
| FRTX Fresh Tracks Therapeutics, | F Tax w/h | 2023-10-02 | 2023-10-04 | 7,358 | $0.98 | $7.2K | 16,061 | SEC↗ |
| FRTX Fresh Tracks Therapeutics, | M Exercise | 2023-10-02 | 2023-10-04 | 20,000 | — | $0 | 23,419 | SEC↗ |
| FRTX Fresh Tracks Therapeutics, | A Award deriv | 2023-01-24 | 2023-01-26 | 20,000 | — | $0 | 20,000 | SEC↗ |
| BBI Brickell Biotech, Inc. | A Award deriv | 2022-05-05 | 2022-05-09 | 300,000 | — | $0 | 300,000 | SEC↗ |
| BBI Brickell Biotech, Inc. | P Buy | 2021-07-23 | 2021-07-27 | 18,124 | $0.67 | $12.1K | 128,879 | SEC↗ |
| BBI Brickell Biotech, Inc. | A Award deriv | 2021-06-14 | 2021-06-14 | 200,000 | — | $0 | 200,000 | SEC↗ |
| BBI Brickell Biotech, Inc. | P Buy | 2021-05-17 | 2021-05-19 | 18,622 | $0.80 | $14.9K | 110,755 | SEC↗ |
| BBI Brickell Biotech, Inc. | P Buy | 2021-05-17 | 2021-05-19 | 7,980 | $0.80 | $6.4K | 13,980 | SEC↗ |
| BBI Brickell Biotech, Inc. | M Exercise deriv | 2021-03-16 | 2021-03-17 | 25,000 | — | $0 | 0 | SEC↗ |
| BBI Brickell Biotech, Inc. | M Exercise | 2021-03-16 | 2021-03-17 | 25,000 | — | $0 | 100,883 | SEC↗ |
| BBI Brickell Biotech, Inc. | F Tax w/h | 2021-03-16 | 2021-03-17 | 8,750 | $1.14 | $10.0K | 92,133 | SEC↗ |
| BBI Brickell Biotech, Inc. | P Buy | 2020-09-18 | 2020-09-21 | 16,526 | $0.83 | $13.7K | 75,883 | SEC↗ |
| BBI Brickell Biotech, Inc. | P Buy | 2020-09-18 | 2020-09-21 | 6,000 | $0.84 | $5.0K | 6,000 | SEC↗ |
| BBI Brickell Biotech, Inc. | A Award deriv | 2020-09-15 | 2020-09-17 | 350,000 | — | $0 | 350,000 | SEC↗ |
| BBI Brickell Biotech, Inc. | P Buy deriv | 2020-06-22 | 2020-06-22 | 30,435 | — | $0 | 30,435 | SEC↗ |
| BBI Brickell Biotech, Inc. | P Buy | 2020-06-22 | 2020-06-22 | 30,435 | — | $0 | 59,357 | SEC↗ |
| BBI Brickell Biotech, Inc. | A Award deriv | 2020-03-16 | 2020-03-18 | 25,000 | $1.54 | $38.5K | 25,000 | SEC↗ |
| ECYT ENDOCYTE INC | D To issuer deriv | 2018-12-21 | 2018-12-21 | 37,500 | $21.04 | $789.0K | 0 | SEC↗ |
| ECYT ENDOCYTE INC | D To issuer | 2018-12-21 | 2018-12-21 | 2,119 | $24.00 | $50.9K | 0 | SEC↗ |
| ECYT ENDOCYTE INC | D To issuer | 2018-12-21 | 2018-12-21 | 23,750 | $24.00 | $570.0K | 0 | SEC↗ |